Bellevue Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,606,636
| Closed | -$38.1M | – | 235 |
|
|
2020
Q4 | $38.1M | Buy |
2,606,636
+1,342,825
| +106% | +$19.6M | 0.44% | 66 |
|
|
2020
Q3 | $17.9M | Sell |
1,263,811
-225,473
| -15% | -$3.2M | 0.25% | 95 |
|
|
2020
Q2 | $21.9M | Sell |
1,489,284
-922,642
| -38% | -$13.6M | 0.31% | 76 |
|
|
2020
Q1 | $9.94M | Sell |
2,411,926
-29,315
| -1% | -$121K | 0.19% | 89 |
|
|
2019
Q4 | $11.7M | Buy |
2,441,241
+173,989
| +8% | +$837K | 0.19% | 85 |
|
|
2019
Q3 | $13.7M | Sell |
2,267,252
-85,815
| -4% | -$520K | 0.26% | 73 |
|
|
2019
Q2 | $15.3M | Hold |
2,353,067
| – | – | 0.26% | 67 |
|
|
2019
Q1 | $16.7M | Buy |
2,353,067
+353,527
| +18% | +$2.51M | 0.92% | 35 |
|
|
2018
Q4 | $9.72M | Buy |
1,999,540
+660,038
| +49% | +$3.21M | 0.64% | 44 |
|
|
2018
Q3 | $9.85M | Buy |
1,339,502
+153,000
| +13% | +$1.12M | 0.62% | 51 |
|
|
2018
Q2 | $7.57M | Hold |
1,186,502
| – | – | 0.65% | 50 |
|
|
2018
Q1 | $6.46M | Buy |
1,186,502
+412,825
| +53% | +$2.25M | 0.64% | 52 |
|
|
2017
Q4 | $3.23M | Buy |
773,677
+250,000
| +48% | +$1.04M | 0.34% | 63 |
|
|
2017
Q3 | $5.04M | Buy |
523,677
+118,499
| +29% | +$1.14M | 0.53% | 53 |
|
|
2017
Q2 | $4.79M | Buy |
405,178
+92,512
| +30% | +$1.09M | 0.57% | 59 |
|
|
2017
Q1 | $4.01M | Buy |
+312,666
| New | +$4.01M | 0.53% | 54 |
|